Readers of MassTortDefense know how the conduct and results of clinical trials can reach out and affect later product liability litigation: plaintiffs
Continue Reading PhRMA Issues New Principles on Clinical Trials
clinical trials
FDA Issues Guidance For Industry On Retaining Data From Clinical Trials
By Sean Wajert on
Posted in Articles, Drug and Device
Limiting mass tort/class action exposure is a key part of the role of in-house litigators. In the drug and device areas, limiting plaintiffs’ ability …
Continue Reading FDA Issues Guidance For Industry On Retaining Data From Clinical Trials